• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院患者阿片类药物使用障碍的诊断与管理。

Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.

机构信息

Division of Hospital Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, New York, NY 10029, USA.

Department of Medical Education, Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, New York, NY 10029, USA.

出版信息

Med Clin North Am. 2020 Jul;104(4):695-708. doi: 10.1016/j.mcna.2020.03.003. Epub 2020 May 12.

DOI:10.1016/j.mcna.2020.03.003
PMID:32505261
Abstract

The diagnosis of opioid use disorder (OUD) is often overlooked or inadequately managed during the inpatient admission. When recognized, a common strategy is opioid detoxification, an approach that is often ineffective and can be potentially dangerous because of loss of tolerance and subsequent risk for overdose. Medication for addiction treatment (MAT), including methadone and buprenorphine, is effective and can be dispensed in the hospital for both opioid withdrawal and initiation of maintenance treatment. Hospitalists should be knowledgeable about diagnosing and managing patients with OUD, including how to manage acute pain or MAT during the perioperative setting.

摘要

阿片类使用障碍(OUD)的诊断在住院期间经常被忽视或处理不当。当被识别出来时,一种常见的策略是阿片类药物脱毒,这种方法通常是无效的,而且由于耐受性丧失和随后的过量风险,可能是危险的。药物成瘾治疗(MAT),包括美沙酮和丁丙诺啡,是有效的,可以在医院开出,用于治疗阿片类药物戒断和启动维持治疗。医院医生应该了解如何诊断和治疗 OUD 患者,包括如何在围手术期管理急性疼痛或 MAT。

相似文献

1
Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.住院患者阿片类药物使用障碍的诊断与管理。
Med Clin North Am. 2020 Jul;104(4):695-708. doi: 10.1016/j.mcna.2020.03.003. Epub 2020 May 12.
2
Medications for management of opioid use disorder.阿片类药物使用障碍的药物治疗。
Am J Health Syst Pharm. 2019 Jul 18;76(15):1097-1103. doi: 10.1093/ajhp/zxz105.
3
Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.医院环境中阿片类药物戒断的管理和阿片类药物使用障碍药物的启用。
Hosp Pract (1995). 2022 Oct;50(4):251-258. doi: 10.1080/21548331.2022.2102776. Epub 2022 Jul 22.
4
The case for a medication first approach to the treatment of opioid use disorder.采用药物优先治疗阿片类药物使用障碍。
Am J Drug Alcohol Abuse. 2019;45(4):333-340. doi: 10.1080/00952990.2019.1605372. Epub 2019 May 14.
5
Maintenance medication for opiate addiction: the foundation of recovery.阿片类药物成瘾维持治疗药物:康复的基础。
J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598.
6
CE: Acute Pain Management for People with Opioid Use Disorder.CE:阿片类药物使用障碍患者的急性疼痛管理
Am J Nurs. 2018 Oct;118(10):30-38. doi: 10.1097/01.NAJ.0000546378.81550.84.
7
Caring for patients with opioid use disorder in the hospital.在医院护理患有阿片类物质使用障碍的患者。
CMAJ. 2016 Dec 6;188(17-18):1232-1239. doi: 10.1503/cmaj.160290. Epub 2016 Sep 19.
8
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.不同阿片类药物使用障碍治疗途径的疗效比较。
JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworkopen.2019.20622.
9
Pharmacological treatment of opioid use disorder in pregnancy.妊娠期阿片类药物使用障碍的药物治疗。
Semin Perinatol. 2019 Apr;43(3):141-148. doi: 10.1053/j.semperi.2019.01.003. Epub 2019 Jan 21.
10
Update on pharmacotherapy for treatment of opioid use disorder.阿片类物质使用障碍治疗的药物治疗进展
Expert Opin Pharmacother. 2016 Dec;17(17):2307-2318. doi: 10.1080/14656566.2016.1244529. Epub 2016 Oct 20.

引用本文的文献

1
Narrative review: Managing buprenorphine and opioid use disorder in the perioperative setting.叙述性综述:围手术期丁丙诺啡与阿片类物质使用障碍的管理
Pain Pract. 2025 Jan;25(1):e13427. doi: 10.1111/papr.13427. Epub 2024 Oct 25.
2
Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population.危重症人群舌下含服丁丙诺啡的应用实践与结果
Crit Care Explor. 2024 Mar 12;6(3):e1062. doi: 10.1097/CCE.0000000000001062. eCollection 2024 Mar.
3
"They make it too hard and too many hoops to jump": system and organizational barriers to drug treatment during epidemic rates of opioid overdose.
“他们设置了太多的障碍和繁琐的程序”:在阿片类药物过量流行期间,药物治疗面临的系统和组织障碍。
Harm Reduct J. 2024 Feb 27;21(1):52. doi: 10.1186/s12954-024-00964-5.
4
Impact of Potential Case Misclassification by Administrative Diagnostic Codes on Outcome Assessment of Observational Study for People Who Inject Drugs.行政诊断编码导致的潜在病例错误分类对注射吸毒者观察性研究结果评估的影响
Open Forum Infect Dis. 2024 Jan 16;11(2):ofae030. doi: 10.1093/ofid/ofae030. eCollection 2024 Feb.
5
Guanfacine Treatment in a Patient with Intravenous Buprenorphine/Naloxone Misuse.用胍法辛治疗一名静脉注射丁丙诺啡/纳洛酮滥用患者。
Case Rep Psychiatry. 2024 Jan 19;2024:6359691. doi: 10.1155/2024/6359691. eCollection 2024.
6
AKAP150 from nucleus accumbens dopamine D1 and D2 receptor-expressing medium spiny neurons regulates morphine withdrawal.伏隔核中表达多巴胺D1和D2受体的中型多棘神经元中的AKAP150调节吗啡戒断反应。
iScience. 2023 Oct 17;26(11):108227. doi: 10.1016/j.isci.2023.108227. eCollection 2023 Nov 17.
7
The Other Epidemic.另一场流行病。
HCA Healthc J Med. 2020 Jun 27;1(3):119-122. doi: 10.36518/2689-0216.1124. eCollection 2020.
8
Acupuncture for protracted amphetamine abstinence syndrome: study protocol for a systematic review and meta-analysis.针刺治疗阿片类物质戒断延长综合征的系统评价和荟萃分析研究方案。
BMJ Open. 2023 Apr 21;13(4):e062491. doi: 10.1136/bmjopen-2022-062491.
9
Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service.物质使用障碍咨询服务所诊治的住院患者的阿片类激动剂治疗启动及衔接
Drug Alcohol Depend Rep. 2022 Feb 7;2:100031. doi: 10.1016/j.dadr.2022.100031. eCollection 2022 Mar.
10
Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes.在住院成瘾分诊团队中增加一名临床药剂师从业者及相关药物治疗结果。
Ment Health Clin. 2022 Aug 23;12(4):219-224. doi: 10.9740/mhc.2022.08.219. eCollection 2022 Aug.